GGrantIndex
← Search

THE PRIMARY OBJECTIVE OF OUR PROPOSAL IS TO DEVELOP AN ALTERNATIVE TREATMENT FOR POST-FLIGHT MOTION SICKNESS TREATMENT THAT CAN EFFECTIVELY MANAGE SYMPTOMS WITHOUT IMPACTING FUNCTIONAL PERFORMANCE ON CRITICAL CREW EGRESS TASKS.

$142,764FY2021National Aeronautics and Space AdministrationNASA

Mayo Clinic Arizona, Scottsdale AZ

Investigators

View source on USAspending →